text_1: Diabetic patients with acute coronary syndrome experience decreased short-term and long-term risk for bleeding events.
text_2: Because this disease may be associated with increased platelet aggregation, we investigated whether diabetic patients with ACS derive particular benefit from platelet glycoprotein (GP) IIb/IIIa receptor inhibition.